Editorial · 27 Jan 2021
EditorialPublished 2012
Why “Chemotherapy” Should be an Open Access Journal
Subjects
Oncology & CancerSimilar by topic
Short communication · 11 Oct 2022
Hepatic Arterial Infusion Chemotherapy (HAIC) Combined with Regorafenib and PD-1 Inhibitors in the Treatment of Liver Metastases of Colorectal Cancer after Failure of Second-Line Chemotherapy: A Single-Arm Prospective, Open-Label Phase II Clinical Tr
Short communication · 2022
Hepatic Arterial Infusion Chemotherapy (HAIC) Combined with Regorafenib and PD-1 Inhibitors in the Treatment of Liver Metastases of Colorectal Cancer after Failure of Second-Line Chemotherapy: A Single-Arm Prospective, Open-Label Phase II Clinical Trial
Conference abstract · Sep 2020
Study to trace palliative treatment options for Metastatic triple negative breast cancer MTNBC patients who progress beyond second line chemotherapy through open discussions
Conference abstract · 2016
Attention of cancer care for totally implantable venous-access ports associate complications the latest 6 years analysis of 400 cancer chemotherapy patients
More from this journal
The newest in Chemotherapy: Open Access.
Perspective · 3 Nov 2025
Vulvar and Vaginal Cancers Clinical Characteristics Treatment Options and Prognosis
Opinion · 3 Nov 2025
Evaluation of Surgical Radiotherapy and Chemotherapy in the Treatment of Gynaecological Malignancies
Research article · 18 Aug 2025
Response Evaluation to Oxaliplatin-Based Adjuvant Chemotherapy after Curative Resection between Right and Left-Sided Stage II and III Colon Cancer: A Retrospective Survival Analysis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalChemotherapy: Open Access
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Amit K. Maiti”

